Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.
Quick Stats
May 15, 202653.9
AI Score
HOLD0.14
Volume Ratio
May 14, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
GLUE Stock Summary
Last updated May 15, 2026
GLUE is currently trading at $18.5, positioned above its 200-day moving average of $14.29, indicating a long-term uptrend. The stock has a 52-week range of $3.81 to $25.77.
Technical Analysis: The 50-day moving average stands at $17.86, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 44.338, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.029, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GLUE at 53.9/100 with a HOLD recommendation.
GLUE (Monte Rosa Therapeutics, Inc. Common Stock) Indicators
Last updated May 15, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.338 |
| CMF (20) | -0.029 |
| ROC (10) | -3.457 |
| ADX (14) | 31.474 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.185 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -93.413 |
| MFI (14) | 42.419 |
GLUE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GLUE Price vs Max Options Open Interest
GLUE Max Change In Options Open Interest
GLUE Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GLUE Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GLUE Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GLUE Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Monte Rosa Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
GLUE Moving Averages Analysis
Monte Rosa Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on May 15, 2026
Monte Rosa Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 15, 2026
GLUE (Monte Rosa Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated May 15, 2026
| Days | MA |
|---|---|
| 10 | 19.37 |
| 20 | 19.51 |
| 30 | 18.96 |
| 50 | 17.86 |
| 100 | 18.85 |
| 200 | 14.29 |
GLUE Fundamental Analysis
| P/E (Forward) | 10.02 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.6 billion |
| Earnings/Share ($) | -1.48 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.4841 |
| EPS Estimate Next Year ($) | -1.759 |
| WallStreet Target Price ($) | 32.3333 |
| Most Recent Quarter |